SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062025
Filing Date
2023-11-09
Accepted
2023-11-09 16:07:35
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q revb-20230930.htm   iXBRL 10-Q 2004211
2 EX-31.1 revb-ex31_1.htm EX-31.1 34958
3 EX-31.2 revb-ex31_2.htm EX-31.2 35018
4 EX-32.1 revb-ex32_1.htm EX-32.1 12689
5 EX-32.2 revb-ex32_2.htm EX-32.2 12593
  Complete submission text file 0000950170-23-062025.txt   7890260

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20230930_def.xml EX-101.DEF 336420
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20230930_pre.xml EX-101.PRE 434630
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT revb-20230930_cal.xml EX-101.CAL 31956
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20230930_lab.xml EX-101.LAB 476263
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20230930.xsd EX-101.SCH 63486
59 EXTRACTED XBRL INSTANCE DOCUMENT revb-20230930_htm.xml XML 1136643
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39603 | Film No.: 231392381
SIC: 2834 Pharmaceutical Preparations